Running a marathon induces changes in adipokine levels and in markers of cartilage degradation - Novel role for resistin

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vuolteenaho, Katriina ^a   Leppänen, Tiina ^a   Kekkonen, Riina ^b   Korpela, Riitta ^b   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHITINASE; CHITINASE 3 LIKE PROTEIN 1; LEPTIN; RESISTIN; STROMELYSIN; UNCLASSIFIED DRUG; CHI3L1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BLOOD SAMPLING; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MARKER; EXERCISE INTENSITY; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MARATHON RUNNER; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; RUNNING; TISSUE DISTRIBUTION; TURNOVER TIME; BLOOD; BODY MASS; METABOLISM; MIDDLE AGED;

ADIPOKINES; ADIPONECTIN; ADULT; BODY MASS INDEX; CARTILAGE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; HUMANS; LECTINS; LEPTIN; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; RESISTIN; RUNNING;

EID: 84908191250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110481     Document Type: Article

References (41)

1. Rowe GC, Safdar A, Arany Z (2014) Running forward: new frontiers in endurance exercise biology. Circulation 129: 798-810.
2. Ihalainen J, Walker S, Paulsen G., Häkkinen K, Kraemer WJ, et al. (2014) Acute leukocyte, cytokine and adipocytokine responses to maximal and hypertrophic resistance exercise bouts. Eur J Appl Physiol.
3. Hunter DJ, Eckstein F (2009) Exercise and osteoarthritis. J Anat 214: 197-207.
4. Mosher TJ, Liu Y, Torok CM (2010) Functional cartilage MRI T2 mapping: evaluating the effect of age and training on knee cartilage response to running. Osteoarthritis Cartilage 18: 358-64.
5. Neidhart M, Muller-Ladner U, Frey W., Bosserhoff AK, Colombani PC, et al. (2000) Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 8: 222-9.
6. Kersting UG, Stubendorff JJ, Schmidt M.C., Bruggemann GP (2005) Changes in knee cartilage volume and serum COMP concentration after running exercise. Osteoarthritis Cartilage 13: 925-34.
7. Kim HJ, Lee YH, Kim CK (2007) Biomarkers of muscle and cartilage damage and inflammation during a 200 km run. Eur J Appl Physiol 99: 443-7.
8. Kim HJ, Lee YH, Kim CK (2009) Changes in serum cartilage oligomeric matrix protein (COMP), plasma CPK and plasma hs-CRP in relation to running distance in a marathon (42.195 km) and an ultra-marathon (200 km) race. Eur J Appl Physiol 105: 765-70.
9. Niehoff A, Kersting UG, Helling S, Dargel J., Maurer J, et al. (2010) Different mechanical loading protocols influence serum cartilage oligomeric matrix protein levels in young healthy humans. Eur J Appl Physiol 110: 651-7.
10. Helmark IC, Petersen MC, Christensen H.E., Kjaer M., Langberg H (2012) Moderate loading of the human osteoarthritic knee joint leads to lowering of intraarticular cartilage oligomeric matrix protein. Rheumatol Int 32: 1009-14.
11. Niehoff A, Muller M, Bruggemann L., Savage T, Zaucke F, et al. (2011) Deformational behaviour of knee cartilage and changes in serum cartilage oligomeric matrix protein (COMP) after running and drop landing. Osteoar-thritis Cartilage 19: 1003-10.
12. Henrotin Y, Labasse A, Franck T., Bosseloir A, Bury T, et al. (2013) Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. Springerplus 2: 92.
13. Bernecker C, Scherr J, Schinner S., Braun S, Scherbaum WA, et al. (2013) Evidence for an exercise induced increase of TNF-alpha and IL-6 in marathon runners. Scand J Med Sci Sports 23: 207-14.
14. Ouchi N, Parker JL, Lugus J.J., Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
15. Koskinen A, Juslin S, Nieminen R., Moilanen T, Vuolteenaho K, et al. (2011) Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 13: R184.
16. Koskinen A, Vuolteenaho K, Nieminen R., Moilanen T, Moilanen E (2011) Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin Exp Rheumatol 29: 57-64.
17. Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48: 404-9.
18. 2, IL-6, and IL-8 production. Mediators Inflamm 2009: 345838.
19. Koistinen HA, Tuominen JA, Ebeling P, Heiman M.L., Stephens TW, et al. (1998) The effect of exercise on leptin concentration in healthy men and in type 1 diabetic patients. Med Sci Sports Exerc 30: 805-10.
20. Leal-Cerro A, Garcia-Luna PP, Astorga R., Parejo J, Peino R, et al. (1998) Serum leptin levels in male marathon athletes before and after the marathon run. J Clin Endocrinol Metab 83: 2376-9.
21. Karamouzis I, Karamouzis M, Vrabas I.S., Christoulas K., Kyriazis N, et al. (2002) The effects of marathon swimming on serum leptin and plasma neuropeptide Y levels. Clin Chem Lab Med 40: 132-6.
22. Zaccaria M, Ermolao A, Roi G.S., Englaro P., Tegon G, et al. (2002) Leptin reduction after endurance races differing in duration and energy expenditure. Eur J Appl Physiol 87: 108-11.
23. Dill DB, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37: 247-8.
24. Kraus VB, Burnett B, Coindreau J., Cottrell S, Eyre D, et al. (2011) Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 19: 515-42.
25. Scotece M, Conde J, Vuolteenaho K., Koskinen A, Lopez V, et al. (2014) Adipokines as drug targets in joint and bone disease. Drug Discov Today 19: 241-58.
26. Bouassida A, Chamari K, Zaouali M., Feki Y, Zbidi A, et al. (2010) Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med 44: 620-30.
27. Tarkowski A, Bjersing J, Shestakov A., Bokarewa MI (2010) Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med 14: 1419-31.
28. Bokarewa M, Nagaev I, Dahlberg L., Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789-95.
29. Zhang Z, Xing X, Hensley G., Chang LW, Liao W, et al. (2010) Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 62: 1993-2003.
30. Lee JH, Ort T, Ma K., Picha K, Carton J, et al. (2009) Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthritis Cartilage 17: 613-20.
31. Perseghin G, Burska A, Lattuada G., Alberti G, Costantino F, et al. (2006) Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 49: 1893-900.
32. Thommesen L, Stunes AK, Monjo M, Grosvik K., Tamburstuen MV, et al. (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 99: 824-34.
33. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson M.R., et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98: 2005-10.
34. Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440: 213-21.
35. Thomas AW, Davies NA, Moir H, Watkeys L., Ruffino JS, et al. (2012) Exercise-associated generation of PPARgamma ligands activates PPARgamma signaling events and upregulates genes related to lipid metabolism. J Appl Physiol (1985) 112: 806-15.
36. Banga A, Unal R, Tripathi P., Pokrovskaya I, Owens RJ, et al. (2009) Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 296: E480-9.
37. Umpierre D, Ribeiro PA, Kramer C.K., Leitao CB, Zucatti AT, et al. (2011) Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 305: 1790-9.
38. Ferguson MA, White LJ, McCoy S, Kim H.W., Petty T., et al. (2004) Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 91: 324-9.
39. Punyadeera C, Zorenc AH, Koopman R, McAinch A.J., Smit E., et al. (2005) The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 152: 427-36.
40. Vuolteenaho K, Moilanen T, al-Saffar N, Knowles R.G., Moilanen E (2001) Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage. Osteoarthritis Cartilage 9: 597-605.
41. Holzmann J, Brandl N, Zemann A., Schabus R, Marlovits S, et al. (2006) Assorted effects of TGFbeta and chondroitinsulfate on p38 and ERK1/2 activation levels in human articular chondrocytes stimulated with LPS. Osteoarthritis Cartilage 14: 519-25.